CBD-Focused MediPharm Labs Clears All Of Its $41M Convertible Debt, Reports Strong Cash Position
CBD-focused pharmaceutical company MediPharm Labs Corp. (TSXV:) (OTCQX: MEDIF) (FSE:MLZ) revealed Wednesday it has finalized all payments required under its 2020 $41 million unsecured convertible debt.
